These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26175634)

  • 21. [Oral anticoagulants treatment of thrombosis].
    Matsuda T
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1523-7. PubMed ID: 8537761
    [No Abstract]   [Full Text] [Related]  

  • 22. Target-specific oral anticoagulants for stroke prevention in patients with atrial fibrillation: real-world considerations.
    Rosenberg DJ; Ansell J
    Hosp Pract (1995); 2012 Aug; 40(3):50-7. PubMed ID: 23086094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient factors that influence warfarin dose response.
    White PJ
    J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral anticoagulants: the move beyond warfarin.
    Frei J; Carroll VS
    J Neurosci Nurs; 2014 Oct; 46(5):253-5. PubMed ID: 25188682
    [No Abstract]   [Full Text] [Related]  

  • 25. [Companion Diagnostics for Thrombotic Disease].
    Masuda Y; Matsuno K; Shimizu C
    Rinsho Byori; 2015 Nov; 63(11):1316-22. PubMed ID: 26995878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel oral anticoagulants for stroke prevention in atrial fibrillation.
    Taylor J
    Eur Heart J; 2012 Jun; 33(12):1419-20. PubMed ID: 22880211
    [No Abstract]   [Full Text] [Related]  

  • 27. Study of warfarin patients investigating attitudes toward therapy change (SWITCH Survey).
    Attaya S; Bornstein T; Ronquillo N; Volgman R; Braun LT; Trohman R; Volgman A
    Am J Ther; 2012 Nov; 19(6):432-5. PubMed ID: 22198071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.
    Destephan C; Waller AH; Patel RJ; Dhruvakumar S; Mazza V; Gerula C; Maher J; Kaluski E
    Minerva Cardioangiol; 2012 Aug; 60(4):425-31. PubMed ID: 22858920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining aspirin with oral anticoagulant therapy: is this a safe and effective practice in patients with atrial fibrillation?
    Gorelick PB
    Stroke; 2007 May; 38(5):1652-4. PubMed ID: 17395857
    [No Abstract]   [Full Text] [Related]  

  • 30. Self-managed oral anticoagulation therapy.
    Marasinghe JP; Amarasinghe AA
    CMAJ; 2007 Mar; 176(6):813; author reply 813-4. PubMed ID: 17353543
    [No Abstract]   [Full Text] [Related]  

  • 31. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
    Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
    J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial.
    Eisen A; Giugliano RP; Ruff CT; Nordio F; Gogia HS; Awasty VR; Henderson DA; Mercuri MF; Rutman H; Antman EM; Braunwald E
    Am Heart J; 2016 Feb; 172():144-51. PubMed ID: 26856226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey.
    Lip GY; Bongiorni MG; Dobreanu D; Lewalter T; Hastrup Svendsen J; Blomström-Lundqvist C;
    Europace; 2013 Oct; 15(10):1526-32. PubMed ID: 24072770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral anticoagulant therapy in patients with atrial fibrillation.
    Pengo V
    Semin Vasc Med; 2003 Aug; 3(3):333-8. PubMed ID: 15199467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct thrombin inhibition and stroke prevention in elderly patients with atrial fibrillation: experience from the SPORTIF III and V Trials.
    Ford GA; Choy AM; Deedwania P; Karalis DG; Lindholm CJ; Pluta W; Frison L; Olsson SB;
    Stroke; 2007 Nov; 38(11):2965-71. PubMed ID: 17885258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation.
    Lam YY; Ma TK; Yan BP
    Int J Cardiol; 2011 Jul; 150(1):4-11. PubMed ID: 21112648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updated guidelines on outpatient anticoagulation.
    Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
    Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?
    Zikria J; Ansell J
    Discov Med; 2009 Dec; 8(43):196-203. PubMed ID: 20040270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [From warfarin to new oral anticoagulants in clinical practice. What is the future of anticoagulant therapy in atrial fibrillation?].
    Colivicchi F
    Monaldi Arch Chest Dis; 2013 Jun; 80(2):55-6. PubMed ID: 24494406
    [No Abstract]   [Full Text] [Related]  

  • 40. How can we improve our use of oral anticoagulants?
    Alpert JS
    Am J Med; 2006 Feb; 119(2):101-2. PubMed ID: 16443407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.